Charlotte Runge

Charlotte Runge

Auto-generated profile, based on publicly available information

Charlotte Runge

Center for Elective Surgery, Silkeborg Regional Hospital, Silkeborg, Denmark

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2018 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
CRC. Runge
C. Runge
SBS. Bjørn
S. Bjørn
JJJ. M. Jensen
J. M. Jensen
NNN. D. Nielsen
N. D. Nielsen
MVM. Vase
M. Vase
TBThomas Fichtner Bendtsen
Thomas Fichtner Bendtsen

18 September 2024 in Pain
Verified
Journal Article
Closed access
NPNicholas Papadomanolakis-Pakis
Nicholas Papadomanolakis-Pakis
SHSimon Haroutounian
Simon Haroutounian
JSJohan Kløvgaard Sørensen
Johan Kløvgaard Sørensen
CRCharlotte Runge
Charlotte Runge
LBLone Dragnes Brix
Lone Dragnes Brix
LNLone Nikolajsen
Lone Nikolajsen
Chronic postsurgical pain (CPSP) is a highly prevalent condition. To improve CPSP management, we aimed to develop and internally validate generalizable point-of-care risk tools for preoperative and postoperative prediction of CPSP 3 months after surgery. A multicentre, prospective, cohort study in adult patients undergoing elective surgery was conducted between May 2021 and May 2023. Prediction models were developed for the primary outcome according to the International Association for the Study of Pain criteria and a secondary threshold-based CPSP outcome. Models were developed with multivariable logistic regression and backward stepwise selection. Internal validation was conducted using bootstrap resampling, and optimism was corrected by shrinkage of predictor weights. Model performance was assessed by discrimination and calibration. Clinical utility was assessed by decision curve analysis. The final cohort included 960 patients, 16.3% experienced CPSP according to the primary outcome and 33.6% according to the secondary outcome. The primary CPSP model included age and presence of other preoperative pain. Predictors in the threshold-based models associated with an increased risk of CPSP included younger age, female sex, preoperative pain in the surgical area, other preoperative pain, orthopedic surgery, minimally invasive surgery, expected surgery duration, and acute postsurgical pain intensity. Optimism-corrected area-under-the-receiver-operating curves for preoperative and postoperative threshold-based models were 0.748 and 0.747, respectively. These models demonstrated good calibration and clinical utility. The primary CPSP model demonstrated fair predictive performance including 2 significant predictors. Derivation of a generalizable risk tool with point-of-care predictors was possible for the threshold-based CPSP models but requires independent validation.

3 September 2025 in Pain Reports
Verified
Journal Article
Open access
NPNicholas Papadomanolakis-Pakis
Nicholas Papadomanolakis-Pakis
SHSimon Haroutounian
Simon Haroutounian
JSJohan K. Sørensen
Johan K. Sørensen
CRCharlotte Runge
Charlotte Runge
LBLone D. Brix
Lone D. Brix
LNLone Nikolajsen
Lone Nikolajsen
Introduction: Moderate-to-severe acute postsurgical pain (APSP) is experienced by approximately 30% of surgical patients. Objectives: To improve early APSP management, we developed 2 pragmatic and generalizable point-of-care risk tools to preoperatively predict moderate-to-severe and severe APSP in the postanaesthesia care unit (PACU). Methods: This was a multicenter prospective cohort study of adult patients undergoing elective surgical procedures between May 2021 and May 2023. Candidate predictors were preidentified. Logistic regression was used to develop the models. Internal validation was conducted with bootstrap resampling. Model performance was assessed by discrimination and calibration. Decision curve analysis was conducted to evaluate clinical utility of the models. Results: The final cohort included 1380 patients; 45.1% experienced moderate-to-severe APSP and 12.4% experienced severe APSP in the PACU. Predictors retained in the final models independently associated with increased risk of both moderate-to-severe and severe pain included younger age, female sex, preoperative pain in the surgical area, preoperative opioid use, and longer expected surgery duration. Orthopedic surgery and regional anesthesia were associated with decreased risk of both outcomes. In addition, minimally invasive surgery was associated with increased risk of moderate-to-severe APSP, and other preoperative pain was associated with increased risk of severe APSP. Optimism-corrected area under the receiver operating characteristic curves were 0.75 and 0.72 for moderate-to-severe and severe APSP models, respectively. Both models demonstrated good calibration and beneficial clinical utility. Conclusion: Our models developed using point-of-care data on a heterogeneous surgery sample demonstrated acceptable performance and clinical utility for early APSP prediction. External validation is needed before implementation.

30 January 2025 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
CLChristina Cleveland Westerdahl Laursen
Christina Cleveland Westerdahl Laursen
TLTroels Haxholdt Lunn
Troels Haxholdt Lunn
DHDaniel Hägi‐Pedersen
Daniel Hägi‐Pedersen
ATAnne Sofie Nautrup Therkelsen
Anne Sofie Nautrup Therkelsen
CVClaus Varnum
Claus Varnum
OMOle Mathiesen
Ole Mathiesen

10 May 2025 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Open access
JSJohan Kløvgaard Sørensen
Johan Kløvgaard Sørensen
MJMikkel Schjødt Heide Jensen
Mikkel Schjødt Heide Jensen
UGUlrik Grevstad
Ulrik Grevstad
LNLone Nikolajsen
Lone Nikolajsen
CRCharlotte Runge
Charlotte Runge
Background: Adjunct treatment with a popliteal plexus block (PPB) provides moderate enhancement to multimodal analgesic regimens following total knee arthroplasty while maintaining motor function. However, the optimal anesthetic volume of local anesthetic for PPB remains unknown.Aim: To compare the analgesic effects of PPB with 10 versus 20 mL of local anesthetics as an adjunct to a femoral triangle block after total knee arthroplasty.Methods: This blinded, controlled, randomized clinical trial will include 120 patients, randomly assigned to receive PPB with either 10 or 20 mL of bupivacaine 5 mg/mL. All patients undergo primary total knee arthroplasty under spinal anesthesia and receive a multimodal analgesia regimen, including paracetamol, ibuprofen, opioids, dexamethasone, and a femoral triangle block.Outcomes: Primary outcome is 24‐h postoperative opioid consumption. Secondary outcomes include the frequency of patients with opioid‐free analgesia in the first 24 h after surgery, postoperative pain intensity at rest and during mobilization, postoperative muscle function of the leg, ability to mobilize with crutches 6 h after surgery, and Quality of Recovery‐15 survey at 24 h after surgery.Conclusion: This trial hopes to optimize postoperative pain management after total knee arthroplasty by providing valuable insights into the optimal analgesic volume for PPB.Trial Registration: Danish Data Protection Agency: 693807, clinicaltrials.gov: NCT06908837, CTIS: 2024‐520204‐26‐00

18 December 2023 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
LBLine Stenholt Bruun
Line Stenholt Bruun
JSJohan Kløvgaard Sørensen
Johan Kløvgaard Sørensen
JLJens Rolighed Larsen
Jens Rolighed Larsen
CRCharlotte Runge
Charlotte Runge